首页> 外文期刊>The International journal of pharmacy practice >Opinions of community pharmacists on the value of a cardiovascular polypill as a means of improving medication compliance
【24h】

Opinions of community pharmacists on the value of a cardiovascular polypill as a means of improving medication compliance

机译:社区药剂师对心血管多药作为改善药物依从性的价值的意见

获取原文
获取原文并翻译 | 示例
       

摘要

Objective Cardiovascular disease is a major public health problem despite established treatment guidelines and significant healthcare expenditure worldwide. Poor medication compliance accounts in part for some of the observed evidence/practice gaps. Trials of fixed-dose combination pills are currently underway, but the attitudes of relevant health professionals to the routine use of a cardiovascular polypill are generally unknown. Pharmacists are a group of providers who play an important role in patient compliance with long-term medications. The objective was to identify the main perceived barriers to compliance and to investigate pharmacists' opinions regarding the routine use of a cardiovascular polypill. Methods The setting was community pharmacies in the metropolitan and greater areas of New South Wales, Australia. Structured questionnaires were administered to a random sample of community pharmacists and peer-to-peer, semi-structured interviews were conducted with a sub-sample. Quantitative data were analysed using SPSS V16.0 and interviews were analysed thematically. Key findings Questionnaires were completed by 72 of the 250 pharmacists invited to participate. The major barrier to cardiovascular medication compliance identified by respondents was polypharmacy. Other barriers included patient disinterest, time constraints and costs. Most pharmacists agreed that a cardiovascular polypill could be one potential solution to poor compliance by simplifying the treatment regimen (73.6% agreed) and reducing patient costs (79.2% agreed). Inability to tailor treatment and to ascribe side effects was among some of the identified concerns. Conclusion The use of a cardiovascular polypill as a means of increasing patient compliance with long-term cardiovascular preventive therapies is seen as potentially valuable by community pharmacists.
机译:目标尽管全世界制定了治疗指南并花费了大量医疗费用,但心血管疾病仍是一个主要的公共卫生问题。药物依从性差的部分原因是一些观察到的证据/实践差距。固定剂量组合药的试验目前正在进行中,但是有关卫生专业人员对常规使用心血管息肉的态度尚不明确。药剂师是一群在长期服药的患者依从性方面发挥重要作用的提供者。目的是确定主要的顺从性障碍,并调查药剂师对常规使用心血管息肉药的意见。方法设置背景为澳大利亚新南威尔士州大城市及更大地区的社区药房。对社区药剂师的随机样本进行了结构化问卷调查,并通过子样本进行了对等,半结构化访谈。使用SPSS V16.0对定量数据进行了分析,并对访谈进行了专题分析。主要发现接受问卷调查的250位药剂师中有72位完成了问卷调查。受访者确定的阻碍心血管药物依从性的主要障碍是多元药房。其他障碍包括患者不感兴趣,时间限制和费用。大多数药剂师同意,通过简化治疗方案(同意率为73.6%)和降低患者费用(同意为79.2%),心血管多药可能是解决依从性差的一种潜在方法。无法确定治疗方案并确定副作用是一些已确定的问题。结论社区药师认为,使用心血管息肉作为增加患者对长期心血管预防疗法依从性的一种手段具有潜在的价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号